From 8.13 to 8.19, 32 cases of financing were included, and the total amount of financing over 100 million yuan exceeded 95%!

Source: Flint Creation Database

[Financing Overview] This week, 32 investment and financing incidents occurred in the medical and health sector across the country, with a cumulative amount of more than 4.
210 billion yuan.
Compared with last week, the number of investment projects increased by 18.
52%, while the amount of financing decreased by 48.
87%
.

[Financing Overview] Compared with last week, the number of investment projects has increased by 18.
52%, while the amount of financing has decreased by 48.
87%
.

[Distribution of financing rounds] From the perspective of financing rounds, most of the financing events this week focused on angels’ rounds of round B, and a total of 22 projects were invested
.

In terms of financing amount, the A+ round received the highest financing amount of 915 million yuan, accounting for 21.

[Distribution of financing rounds] From the perspective of financing amount, the A+ round received the highest financing amount of 915 million yuan, accounting for 21.

Source: Flint Creation Database

[Regional Distribution of Financing] This week's financing projects are mainly distributed in Jiangsu Province (9 cases)
.

In terms of financing amount, Shanghai is the most prominent, with a financing amount of 1.

【Geographical Distribution of Financing】

Source: Flint Creation Database

[Distribution of financing amount] This week, 32 projects received investment, with a cumulative amount exceeding 4.
210 billion yuan, and 14 cases where a single financing amount exceeded 100 million yuan.
The total financing amount was as high as 4.
05 billion yuan, accounting for 95.
13% of the total financing scale this week.

.

[Distribution of financing amount]

Source: Flint Creation Database

[The most popular field for investors] This week, the pharmaceutical field attracted the most money, with a financing amount of more than 1.
219 billion yuan, accounting for 28.
96% of the total financing amount
.

In terms of the number of projects, other fields are the most active

[The most popular areas for investors]

Source: Flint Creation Database

The most noteworthy financing project

The most noteworthy financing project

1.
In the future share announcement, Shanghai Junsheng Supply Chain Management Co.
, Ltd.
("Shanghai Junsheng"), a wholly-owned subsidiary of the company, intends to pay cash to Yu Hao and others to acquire Shanghai Yuanqing Investment Management Co.
, Ltd.
in which it directly or indirectly holds shares.
The company ("Yuanqing Investment") has 100% equity, and Shanghai Shulin Investment Management Co.
, Ltd.
("Shulin Investment") 100% equity
.

1.
In the future share announcement, Shanghai Junsheng Supply Chain Management Co.
, Ltd.
("Shanghai Junsheng"), a wholly-owned subsidiary of the company, intends to pay cash to Yu Hao and others to acquire Shanghai Yuanqing Investment Management Co.
, Ltd.
in which it directly or indirectly holds shares.
The company ("Yuanqing Investment") has 100% equity, and Shanghai Shulin Investment Management Co.
, Ltd.
("Shulin Investment") 100% equity
.

After the completion of this transaction, the company will indirectly hold 29.
86% of the shares of International Medical Center through holding 100% of Yuanqing Investment and Shulin Investment
.

The overall valuation of the International Medical Center does not exceed RMB 3 billion, and the consideration for this acquisition is estimated to not exceed RMB 896 million

2.

On August 16, Sukun Technology completed a new round of 700 million yuan financing at the end of July.
Investors include Goldman Sachs Asset Management, Chunhua Capital, Sequoia China, Yuanyi Capital, Jianjie Asia, Ruizhi Capital, WT Focus on China Fund and Future Innovation Fund

2.

3.
Recently, Zhuhai Technolab Biotechnology Co.
, Ltd.
(hereinafter referred to as “Technomicrolab” or “Trinomab”) announced the completion of nearly 700 million yuan in A+ round of financing
.

This round of financing was jointly completed by CMB International, Shangxin Capital, CICC Capital Kai Tak Fund, Sunshine Ronghui, Interchina Capital, Superstring Capital, and Tianhui Capital

3.
Recently, Zhuhai Technolab Biotechnology Co.
, Ltd.
(hereinafter referred to as “Technomicrolab” or “Trinomab”) announced the completion of nearly 700 million yuan in A+ round of financing
.

This round of financing funds will be used for the company's further industrialization in the new drug pipeline of natural fully human antibodies
.

4.
On August 19, 2021, the pharmaceutical CRO service platform Saifu Pharmaceutical announced the completion of a Series C financing of more than 300 million yuan
.
This round of financing was led by CICC Qide Fund, a subsidiary of CICC Capital, followed by GF Qianhe, Huakong Investment and Baotai Bio.
The funds will be used to continue to promote the capacity building and capacity expansion of Saifu Pharmaceutical's one-stop innovative medicine CRO service platform And team building
.

4.
On August 19, 2021, the pharmaceutical CRO service platform Saifu Pharmaceutical announced the completion of a Series C financing of more than 300 million yuan
.

Liu Yang, Chairman and CEO of SAFE Pharmaceuticals, said: "Next, SAIF Pharmaceuticals will gradually improve the one-stop CRO service platform, continue to consolidate its unique advantages in innovative drugs and innovative therapies, and strive to become a world-class one-stop shop.
The innovative drug CRO service platform contributes to the advancement of the research and development of innovative drugs and innovative therapies in China
.
"

This week's financing amount rankings

This week's financing amount rankings

Active investment institutions in the healthcare industry this week: Sequoia Capital China, Yuanyi Capital, CICC Capital, Haibang Investment (2 each)
.

Source: Flint Creation Database